National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting

Federal Register, Volume 82 Issue 220 (Thursday, November 16, 2017)

Federal Register Volume 82, Number 220 (Thursday, November 16, 2017)

Notices

Page 53512

From the Federal Register Online via the Government Publishing Office www.gpo.gov

FR Doc No: 2017-24761

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health

National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of a meeting of the Division of Intramural Research Board of Scientific Counselors, NIAID. The meeting will be closed to the public as indicated below in accordance with the provisions set forth in section 552b(c)(6), Title 5 U.S.C., as amended for the review, discussion, and evaluation of individual intramural programs and projects conducted by the National Institute of Allergy and Infectious Diseases, including consideration of personnel qualifications and performance, and the competence of individual investigators, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

Name of Committee: Division of Intramural Research Board of Scientific Counselors, NIAID.

Date: December 11-13, 2017.

Time: 8:00 a.m. to 5:00 p.m.

Agenda: To review and evaluate personal qualifications and performance, and competence of individual investigators.

Place: National Institutes of Health, Building 50, 1227/1233, 50 Center Drive, Bethesda, MD 20892.

Contact Person: Steven M. Holland, MD, Ph.D., Chief, Laboratory of Clinical Infectious Diseases, National Institutes of Health/

NIAID, Hatfield Clinical Research Center, Bethesda, MD 20892-1684, 301-402-7684, sholland@mail.nih.gov.

(Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and Transplantation Research; 93.856, Microbiology and Infectious Diseases Research, National Institutes of Health, HHS)

Dated: November 9, 2017.

Natasha M. Copeland,

Program Analyst, Office of Federal Advisory Committee Policy.

FR Doc. 2017-24761 Filed 11-15-17; 8:45 am

BILLING CODE 4140-01-P